• Remco Vellinga, Douglas J Eleveld, StruysMichel M R FMMRFDepartment of Anesthesiology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.Department of Basic and Applied Medical Sciences, Ghent University, Ghent, Belgium., and Johannes P van den Berg.
• Department of Anesthesiology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
• Curr Opin Anaesthesiol. 2023 Oct 1; 36 (5): 602607602-607.

Purpose Of ReviewThere are various pharmacokinetic-dynamic models available, which describe the time course of drug concentration and effect and which can be incorporated into target-controlled infusion (TCI) systems. For anesthesia and sedation, most of these models are derived from narrow patient populations, which restricts applicability for the overall population, including (small) children, elderly, and obese patients. This forces clinicians to select specific models for specific populations.Recent FindingsRecently, general purpose models have been developed for propofol and remifentanil using data from multiple studies and broad, diverse patient groups. General-purpose models might reduce the risks associated with extrapolation, incorrect usage, and unfamiliarity with a specific TCI-model, as they offer less restrictive boundaries (i.e., the patient "doesn't fit in the selected model") compared with the earlier, simpler models. Extrapolation of a model can lead to delayed recovery or inadequate anesthesia. If multiple models for the same drug are implemented in the pump, it is possible to select the wrong model for that specific case; this can be overcome with one general purpose model implemented in the pump.SummaryThis article examines the usability of these general-purpose models in relation to the more traditional models.Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc.

14 keywords...

hide…